We further analyzed the methylation status of IGF2BP2 promoter region in different breast cancer subtypes, and found that the methylation level of IGF2BP2 promoter region in TNBC was lower compared with that in other molecular subtypes (Figure 2B). This evidence concerns the gene IGF2BP2 and breast carcinoma.